ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Adenosine receptors"

  • Abstract Number: 1939 • 2017 ACR/ARHP Annual Meeting

    Dipyridamole, an Ent-1 Adenosine Transporter Inhibitor, Reverts De Osteoclastic Phenotype Induced By Tenofovir

    Francisco Miguel Conesa-Buendia1, Patricia Llamas2, Tuere Wilder3, Patricia Atencio4, Alfonso Cabello5, Miguel Gorgolas4, Bruce Cronstein6, Raquel Largo7, Gabriel Herrero-Beaumont7 and Aranzazu Mediero8, 1Bone and Joint Research Unit, IIS-Fundacion Jimenez Diaz- UAM, Madrid, Spain, 2Bone and Joint Research Unit, IIS-Fundacion Jimenez Díaz-UAM, Madrid, Spain, 3Department of Medicine, Division of Rheumatology, NYU School of Medicine, New York, NY, 4Internal Medicine Department, IIS-Fundacion Jimenez Diaz-UAM, Madrid, Spain, 5Internal MEdicine Department, IIS-Fundacion Jimenez Diaz-UAM, Madrid, Spain, 6Rheumatology, New York University School of Medicine, Division of Rheumatology, New York, NY, 7Bone and Joint Research Unit, IIS-Fundación Jiménez Díaz UAM, Madrid, Spain, 8Bone and Joint Research Unit, Fundación Jiménez Díaz-UAM, Madrid, Spain

    Background/Purpose: Adenosine, generated from the catabolism of adenine nucleotides, modulates cell function by interacting with specific cell-surface receptors (A1R, A2AR, A2BR, A3R). Inhibition of osteoclast…
  • Abstract Number: 2761 • 2017 ACR/ARHP Annual Meeting

    Adenosine Receptor Agonism Protects Against Antiphospholipid Antibody-Mediated Netosis and Venous Thrombosis

    Ramadan A. Ali1, He Meng1, Srilakshmi Yalavarthi1, Yogendra Kanthi1 and Jason S. Knight2, 1University of Michigan, Ann Arbor, MI, 2., University of Michigan, Ann Arbor, MI

    Background/Purpose: We have previously reported that antiphospholipid antibodies (aPL) activate neutrophils and thereby exaggerate neutrophil extracellular trap release (NETosis), which potentially contributes to the thrombotic…
  • Abstract Number: 1100 • 2016 ACR/ARHP Annual Meeting

    Tenofovir, a Nucleoside Analog Reverse Transcriptase Inhibitor for Treatment of HIV, Promotes Osteoclast Differentiation and Decreases Osteoblast Formation By a Mechanism Depending on ATP Release and Adenosine

    Aranzazu Mediero1,2, Patricia Llamas3, Sergio Portal-Nuñez4, Raquel Largo5, Gabriel Herrero-Beaumont5 and Bruce Cronstein6, 1Medicine, Divison of Translational Medicine, NYU School of Medicine, New York City, NY, 2Bone and Joint Research Unit, Fundación Jiménez Díaz UAM, Madrid, Spain, 3Bone and Joint Research Unit, IIS-Fundacion Jimenez Díaz UAM, Madrid, Spain, 4Bone and Joint Research Unit, IIS-Fundación Jimenez Días UAM, Madrid, Spain, 5Bone and Joint Research Unit, IIS-Fundacion Jimenez Diaz UAM, Madrid, Spain, 6Medicine, Division of Rheumatology, NYU School of Medicine, New York, NY

    Background/Purpose:  Human Immunodeficiency Virus (HIV) infection devastates the immune system but also affects tissues and organs such as kidney, liver, central nervous system, heart and…
  • Abstract Number: 1848 • 2016 ACR/ARHP Annual Meeting

    Adenosine A2A Receptor (A2AR) Stimulates Collagen Type III Synthesis Via β-Catenin Activation in Vitro and in Vivo

    Jin Zhang1, Gibran Shaikh2, Carmen Corciulo3, Tuere Wilder3, Miguel Perez-Aso1, Aranzazu Mediero1 and Bruce Cronstein1, 1Medicine, Division of Rheumatology, NYU School of Medicine, New York, NY, 2Department of Medicine, NYU School of Medicine, New York, NY, 3Department of Medicine, Division of Rheumatology, NYU School of Medicine, New York, NY

    Background/Purpose: Fibrosis of skin and other organs is a hallmark of Scleroderma.  We and others have previously reported that A2AR plays a role in skin…
  • Abstract Number: 2129 • 2016 ACR/ARHP Annual Meeting

    Extracellular Adenosine Deficiency Plays a Role in the Pathogenesis of Osteoarthritis (OA) and Adenosine Replacement Prevents Post-Traumatic Osteoarthritis

    Carmen Corciulo1, Matin Lendhey2, Tuere Wilder1, Oran Kennedy2 and Bruce Cronstein3, 1Department of Medicine, Division of Rheumatology, NYU School of Medicine, New York, NY, 2Department of Orthopaedic Surgery, NYU-School of Medicine, New York, NY, 3Medicine, Division of Rheumatology, NYU School of Medicine, New York, NY

    Background/Purpose: Extracellular adenosine is highly regulated and plays an important homeostatic role via occupancy of cell surface receptors (A1R, A2AR, A2BR, A3R).  Mice lacking A2AR…
  • Abstract Number: 2270 • 2016 ACR/ARHP Annual Meeting

    Inflammasome/IL-1β Activation Induced By Calcium Pyrophosphate Dihydrate Crystals Is Mainly Driven By a P2X7 Receptor-Independent Potassium Efflux

    Laure Campillo-Gimenez1, Félix Renaudin2, Pierre Bobé3, Marjolaine Gosset4, Christèle Combes5, Martine Cohen-Solal2,6, Frederic Lioté2,6 and Hang-Korng Ea2,6, 1Hôpital Lariboisière, Centre Viggo Petersen, INSERM UMR1132, Paris Diderot University, Paris, France, 2INSERM UMR1132, Paris Diderot University, Paris, France, 3INSERM UMRS757, Paris Sud University, Orsay, France, 4EA2496, Paris Descartes University, Montrouge, France, 5ENSIACET, CIRIMAT, INPT-UPS-CNRS, Toulouse, France, 6AP-HP, Lariboisière Hospital, Rheumatology Department, Paris, France

    Background/Purpose: Calcium pyrophosphate crystals including monoclinic and triclinic dihydrate phases (m- and t-CPPD) are found in 40% of end-stage osteoarthritis (OA) patients. Frequently asymptomatic, it…
  • Abstract Number: 1613 • 2015 ACR/ARHP Annual Meeting

    Expression of the Genes Facilitating Methotrexate Action within Rheumatoid Subcutaneous Nodules

    Emma Houlder1, Melanie Millier2, John Highton3, Lisa K. Stamp4 and Paul Hessian2, 1Medicine, University of Otago, Dunedin, New Zealand, 2Department of Medicine, University of Otago, Dunedin, New Zealand, 3Dept of Medicine, University of Otago, Dunedin, New Zealand, 4Medicine, University of Otago, Christchurch, Christchurch, New Zealand

    Background/Purpose: Methotrexate (MTX) is the most frequently used DMARD in the treatment of rheumatoid arthritis (RA). There are known links between the use of MTX…
  • Abstract Number: 2010 • 2015 ACR/ARHP Annual Meeting

    Adenosine A2A Receptor, but Not A2B Receptor, Deletion Leads to Development of Osteoarthritis (OA) in Mice and Administration of a Liposomal Suspension of Adenosine Prevents/Treats Osteoarthritis in Rats

    CARMEN CORCIULO1, MATIN Lendhey2, AUSTIN RAMME2, Tuere Wilder3, ORAN KENNEDY2 and Bruce Cronstein4, 1Medicine, NYU-School of Medicine, New York, NY, 2Department of Orthopaedic Surgery, NYU-School of Medicine, New York, NY, 3Dept of Med, Div of Rheum, NYU School of Medicine, New York, NY, 4Medicine, Division of Rheumatology, NYU School of Medicine, NEW YORK, NY

    Background/Purpose: Adenosine, acting at its receptors, regulates chondrocyte function and inflammation, two components of OA. Mice lacking adenosine A2A receptors (A2AR) have increasing difficulty walking…
  • Abstract Number: 2209 • 2015 ACR/ARHP Annual Meeting

    Stimulation of the Adenosine A2A Receptor (A2AR) Regulates the Expression of Netrin-1 (Ntn1) and Its Receptors (Unc5b, DCC) and Inhibits Wear Particle-Induced Inflammatory Osteolysis in a Model of Joint Prosthesis Loosening

    Aranzazu Mediero1, Bhama Ramkhelawon2, Miguel Perez-Aso3, Kathryn Moore2 and Bruce Cronstein4, 1Medicine, Divison of Translational Medicine, NYU School of Medicine, New York City, NY, 2Leon H. Charney Division of Cardiology, Department of Medicine,, NYU School of Medicine, New York, NY, 3Provital S.A., Barberà del Vallès, Spain, 4Medicine, Division of Rheumatology, NYU School of Medicine, NEW YORK, NY

    Background/Purpose: Ntn1 is a member of the family of axonal guidance proteins that plays a role in leukocyte function and inflammation and is critical for…
  • Abstract Number: 2215 • 2015 ACR/ARHP Annual Meeting

    Ticagrelor Regulates Osteoblast and Osteoclast Function and Promotes Bone Formation in Vivo By Increasing Adenosine Levels 

    Aranzazu Mediero1, Tuere Wilder2, Carl Whatling3 and Bruce Cronstein4, 1Medicine, Divison of Translational Medicine, NYU School of Medicine, New York City, NY, 2Dept of Med, Div of Rheum, NYU School of Medicine, New York, NY, 3CVMD Innovative Medicine Unit, Translational Sciences, AstraZeneca R&D, Mölndal, Sweden, 4Medicine, Division of Rheumatology, NYU School of Medicine, NEW YORK, NY

    Background/Purpose: The antiplatelet drugs Ticagrelor and clopidogrel are P2Y12 antagonists but ticagrelor also inhibits cellular adenosine uptake via ENT1 and thereby increases extracellular adenosine levels.…
  • Abstract Number: 2947 • 2014 ACR/ARHP Annual Meeting

    Adenosine a2A Receptor As a Potential New Therapeutic Target for the Prevention/Treatment of Osteoarthritis

    Carmen Corciulo1, Aranzazu Mediero2, Tuere Wilder3 and Bruce N. Cronstein4, 1Division of Translational Medicine, Department of Medicine, NYU School of Medicine, New York, NY, 2Medicine, Division of Translational Medicine, NYU School of Medicine, New York, NY, 3Medicine, division of Translational Medicine, NYU School of Medicine, New York, NY, 4NYU School of Medicine, Division of Rheumatology, New York, NY

    Background/Purpose Osteoarthritis results from trauma, mechanical factors or metabolic changes in bone and cartilage. Adenosine, acting via the A2AR, inhibits inflammation and plays a critical…
  • Abstract Number: 2792 • 2014 ACR/ARHP Annual Meeting

    Methotrexate Prevents Inflammatory Osteolysis By Activation of the Adenosine a2A Receptor (A2AR)

    Aranzazu Mediero1, Tuere Wilder2 and Bruce N. Cronstein3, 1Medicine, Division of Translational Medicine, NYU School of Medicine, New York, NY, 2Medicine, division of Translational Medicine, NYU School of Medicine, New York, NY, 3NYU School of Medicine, Division of Rheumatology, New York, NY

    Background/Purpose Prior studies demonstrate that adenosine, acting at A2AR, mediates the anti-inflammatory effects of methotrexate (MTX) in models of both acute and chronic inflammation. We…
  • Abstract Number: 1729 • 2014 ACR/ARHP Annual Meeting

    Adenosine A2A Receptor (A2AR) Promotes Collagen Type 3 Expression Via β-Catenin Activation

    Miguel Perez-Aso1 and Bruce N. Cronstein2, 1545 1st Ave., New York University, New York City, NY, 2NYU School of Medicine, Division of Rheumatology, New York, NY

    Background/Purpose A2AR stimulation promotes collagen 1 and 3 (Col1 and Col3) synthesis, principal mediators of fibrosis and scarring. We have recently demonstrated that the A2AR…
  • Abstract Number: 22 • 2014 ACR/ARHP Annual Meeting

    Adenosine a2A Receptor (A2AR) Stimulation Inhibits Osteoclast Differentiation and Promotes Osteoblast Formation By Regulation of Axon Guidance Proteins

    Aranzazu Mediero1, Miguel Perez-Aso2 and Bruce N. Cronstein3, 1Medicine, Division of Translational Medicine, NYU School of Medicine, New York, NY, 2545 1st Ave., New York University, New York City, NY, 3NYU School of Medicine, Division of Rheumatology, New York, NY

    Background/Purpose Semaphorins (Sema), axonal guidance proteins, play a role in communication between osteoclast and osteoblast. Thus, sema4D, secreted by osteoclasts, binds to its receptor PlexinB1…
  • Abstract Number: 19 • 2014 ACR/ARHP Annual Meeting

    Adenosine Receptors Stimulate Bone Regeneration

    Aranzazu Mediero1, Tuere Wilder2 and Bruce N. Cronstein3, 1Medicine, Division of Translational Medicine, NYU School of Medicine, New York, NY, 2Medicine, division of Translational Medicine, NYU School of Medicine, New York, NY, 3NYU School of Medicine, Division of Rheumatology, New York, NY

    Background/Purpose Such orthopedic procedures as spinal fusion and repair of bone defects due to trauma, infection or metastatic disease, require formation of new bone. Adenosine,…
  • « Previous Page
  • 1
  • 2
  • 3
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology